オクラホマにおけるクローン病の臨床試験
オクラホマ内の拠点で、クローン病に関する8件の研究が参加者を募集しています。
オクラホマ内の都市
公式研究テキスト（英語）
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Digestive Disease Specialists Inc. ( Site 5117), Oklahoma City
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06430801Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Digestive Disease Specialists - Oklahoma /ID# 265901, Oklahoma City
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Digestive Disease Specialists Inc, Oklahoma City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07499232An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Central Sooner Research-Site Number: 8400094, Norman
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184931A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Digestive Disease Specialists, Inc., Oklahoma City
被験者募集中第4相
18歳〜70歳 · 全性別 · 2026/09/09更新 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Digestive Disease Specialists Inc, Oklahoma City
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07577843A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- The University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/03更新 · NCT06100289A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- The University of Oklahoma Health Sciences Center, Oklahoma City
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。